Back

Fourteen-year risk of MACE stratified by NT-proBNP and inflammatory biomarkers in type 2 diabetes

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predicting cardio-renal-metabolic disease (1) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hashmat Sayed Zohori Bahrami

Steno Diabetes Center, Copenhagen, Herlev (Denmark)

6 More presentations in this session

Presentation thumbnail
Machine learning-based all-cause mortality risk assessment integrating novel biomarkers in patients with suspected or known coronary artery disease: the AI-ANOX-EXCEED-J Study
Doctor H. Wada (Kyoto, JP)
Abstract
Presentation thumbnail
Serum Let-7b and AKT3 predict cardiovascular death in type 2 diabetes: insights from miRNA profiling and target prediction
Miss H. Evirgen (Ankara, TR)
Abstract
Presentation thumbnail
Combined assessment of stress hyperglycemia ratio and hemoglobin glycation index to predict mortality after coronary revascularisation: a machine learning study
Miss L. Runqian (CN)
Abstract
Presentation thumbnail
Relationship between atherosclerotic burden and subclinical cardiac dysfunction in Type 2 Diabetes
Doctor T. Jinadu (Leicester, GB)
Abstract
Presentation thumbnail
Integrating genetic, clinical, and behavioural factors may improve the prediction of type 2 diabetes
Doctor F. Escorcio Silva (Funchal, PT)
Abstract

Access the full session

Session thumbnail
Predicting cardio-renal-metabolic disease (1)

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Analysis of the dynamics and prognostic significance of inflammatory markers in patients with heart failure who underwent acute coronary syndrome and percutaneous coronary intervention
29 June 2021
thumbnail
Congress Presentation
NT-proBNP levels in diabetic cardiomyopathy: results from the ARISE-HF trial
20 May 2023
thumbnail
Congress Presentation
A 4-protein biomarker risk score enhances cardiovascular risk assessment: insights from the multi-ethnic study of atherosclerosis
30 August 2025
thumbnail
Congress Presentation
Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources